AIP and chronic kidney disease: Emerging evidence suggests that elevated AIP reflects phospholipid dysregulation in CKD, driven by phospholipase A2(PLA2)-mediated generation of proinflammatory lysophospholipids such as lysophosphatidylcholine (LysoPC) and lysophosphatidic acid (LysoPA) (45).